Next Article in Journal
In Silico Evaluation of Antifungal Compounds from Marine Sponges against COVID-19-Associated Mucormycosis
Next Article in Special Issue
A Series of New Pyrrole Alkaloids with ALR2 Inhibitory Activities from the Sponge Stylissa massa
Previous Article in Journal / Special Issue
New Sorbicillinoids with Tea Pathogenic Fungus Inhibitory Effect from Marine-Derived Fungus Hypocrea jecorina H8
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Unique Cyclized Thiolopyrrolones from the Marine-Derived Streptomyces sp. BTBU20218885

1
School of Light Industry, Beijing Technology and Business University, Beijing 100048, China
2
Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China
3
School of Ocean Sciences, China University of Geosciences, Beijing 100083, China
4
School of Pharmacy, Tianjin Medical University, Tianjin 300070, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Mar. Drugs 2022, 20(3), 214; https://doi.org/10.3390/md20030214
Submission received: 15 February 2022 / Revised: 16 March 2022 / Accepted: 16 March 2022 / Published: 18 March 2022
(This article belongs to the Special Issue Heterocyclic Compounds from Marine Organisms)

Abstract

:
Two new cyclized thiolopyrrolone derivatives, namely, thiolopyrrolone A (1) and 2,2-dioxidothiolutin (2), together with the kn own compound, thiolutin (3) were identified from a marine-derived Streptomyces sp. BTBU20218885, which was isolated from a mud sample collected from the coastal region of Xiamen, China. Their chemical structures were determined using spectroscopic data, including HRESIMS, 1D and 2D NMR techniques. 1 possessed a unique unsymmetrical sulfur-containing thiolopyrrolone structure. All the compounds were tested for bioactivities against Staphylococcus aureus, Escherichia coli, Bacille Calmette–Guérin (BCG), Mycobacterium tuberculosis, and Candida albicans. 1 displayed antibacterial activities against BCG, M. tuberculosis, and S. aureus with minimum inhibitory concentration (MIC) values of 10, 10, and 100 μg/mL, respectively. Thiolutin (3) showed antibacterial activities against E. coli, BCG, M. tuberculosis, and S. aureus with MIC values of 6.25, 0.3125, 0.625, and 3.125 μg/mL, respectively.

1. Introduction

Infectious diseases caused by infectious microorganisms continue to threaten human health. Moreover, the development of drug resistance by Candida albicans, Staphylococcus aureus, Escherichia coli, and Mycobacterium tuberculosi is becoming more and more serious in hospitals and the community [1,2,3,4]. There is an urgent need to develop new drugs to fight against these pathogens.
Streptomyces belongs to actinomycetes which are highly diverse Gram-positive bacteria with high guanine and cytosine content in their DNA. Actinomycetes are well known as an important resource for screening new antibiotics [5], representing 45% of the bioactive secondary metabolites originating from microorganisms [6]. Moreover, Streptomyces are the key source of many of the world’s antibiotics in clinics [7,8]. With the detailed investigation on marine microorganisms, marine-derived actinomycetes have proven to be an inexhaustible source for bioactive secondary metabolites [9]. A number of new bioactive compounds were characterized from marine-derived Streptomyces, such as isoquinolinequinones [10], terpenoid derivatives [11,12], angucycline derivatives [13,14,15], glycosylated aromatic polyketides [16], bicyclic peptides [17], depsipeptides [18], benzodiazepines [19], and piericidin derivatives [20].
In the course of our screening of antibacterial secondary metabolites from marine-derived actinomycetes [21,22,23,24], the EtOAc extract of Streptomyces sp. BTBU20218885, isolated from a mud sample collected from the coastal area of Xiamen, Fujian Province, China, showed antibacterial activity against Bacille Calmette–Guérin (BCG), the live attenuated vaccine form of Mycobacterium bovis, with minimum inhibitory concentration (MIC) of 20 μg/mL. A chemical investigation of this Streptomyces strain resulted in the isolation of two new cyclized thiolopyrrolone derivatives, namely, thiolopyrrolone A (1) and 2,2-dioxido thiolutin (2), together with the known compound, thiolutin (3) (Figure 1). Details of fermentation, isolation, structural elucidation, and antibacterial activities are reported here.

2. Results

2.1. Structure Elucidation

Compound 1 was isolated as a light-yellow amorphous powder. The molecular formula of 1 was deduced to be C24H24N6O6S4 by the high-resolution electrospray ionization mass spectroscopy (HRESIMS) measurement (m/z [M+H]+ 621.0712, calcd for C24H25N6O6S4, 621.0713), accounting for sixteen degrees of unsaturation (Figure S1). The 1H NMR spectrum (Table 1, Figure S2) showed the presence of three exchangeable singlets (δH 10.27, s, 7-NH; 10.21, s, 7′-NH; 10.17, s, 7″-NH), three olefinic protons (δH 6.58, s, H-3; 6.36, s, H-3′; 6.54, s, H-3″), three N-Me groups (δH 3.19, s, Me-10; 3.47, s, Me-10′; 3.40, s, Me-10″), as well as three methyl singlets for acetyl groups (δH 2.07, s, Me-9 and Me-9″; 2.06, s, Me-9′). The 13C NMR spectrum (Figure S3), in association with the heteronuclear single quantum correlation (HSQC) spectrum (Figure S4), indicated 24 carbon signals (Table 1), including six methyls (δC 29.9, C-10; δC 29.2, C-10′/C-10″; δC 22.9, C-9; δC 22.8, C-9′/C-9″), three sp2 methines (δC 111.9, C-3; δC 112.5, C-3′; δC 112.8, C-3″), six amide carbonyls (δC 164.0/163.7/163.8, C-5/C-5′/C-5″; δC 168.4/168.3/167.9, C-8/C-8′/C-8″), and nine sp2 quaternary carbons (δC 137.1/131.9/133.8, 3a/3a′/3a″; δC 130.7/129.8/132.7, 6/6′/6″; δC 124.6/124.6/126.4, 6a/6a′/6a″). The amide carbonyls and olefinic carbons accounted for twelve degrees of unsaturation, which indicated compound 1 was a tetracyclic molecule. Comparison of the NMR data with those of the known compound thiolutin (3, Table 1) [25] revealed that 1 was an analogue of thiolutin with a pseudo trimer structure. Furthermore, the heteronuclear multiple bond correlation (HMBC) correlations (Figure 2, Figures S5 and S6) from H3-9 and H-7-NH to C-8, H3-9′ and H-7′-NH to C-8′, and H3-9″ and H-7″-NH to C-8″ revealed the presence of three acetamides. The HMBC correlations from H3-10 to C-3a and C-5, H3-10′ to C-3a′ and C-5′, H3-10″ to C-3a″ and C-5″ confirmed the presence of three N-Me amides. The moieties of 1,5-dihydro-2H-pyrrol-2-one were determined by HMBC correlations from H-3 to C-3a and C-6a, H-7-NH to C-6 and C-6a, H-3′ to C-3a′ and C-6a′, H-7′-NH to C-6′ and C-6a′, H-3″ to C-3a″ and C-6a″, H-7″-NH to C-6″ and C-6a″. The monosulfur bonds between C-6a and C-3′, C-6a′ to C-3″ were revealed by the HMBC correlations from H-3′ to C-6a, and H-3″ to C-6a′. The absence of HMBC correlation from H-3 to C-6a″, together with molecular formula of 1, indicated that the C-6a and C-3 were linked through a disulfur bond. Thus, the structure of 1 was established (Figure 1) and named thiolopyrrolone A.
Compound 2 was isolated as a yellow amorphous powder. The molecular formula of 2 was deduced to be C8H8N2O4S2 by the HRESIMS measurement (m/z [M + H]+ 260.9996, calcd for C8H9N2O4S2, 260.9998), accounting for six degrees of unsaturation (Figure S7). The 1H 13C and HSQC spectra (Figures S8–S10) displayed similar signals to those of 3, including one sp2 methine (δH 7.56, s, H-3; δC 109.6, C-3), one N-Me group (δH 3.10, s, H3-10; δC 27.9, C-10), and one methyl singlet for acetyl group (δH 2.10, s, H3-9; δC 22.6, C-9), two amide carbonyls (δC 164.3, C-5; δC 170.5, C-8), and three sp2 quaternary carbons (δC 145.5, C-3; δC 114.1, C-6, δC 123.1, C-6a). The HMBC spectrum (Figure S11) showed correlations from H3-9 to C-8, H3-10 to C-3a and C-5, H-3 to C-3a and C-6a (Figure 2). Together with the molecular formula calculated by HRESIMS, there are two more oxygen atoms in compound 2. So there are four possible structures for 2 as shown in Figure 3. The two oxygen atoms for sulfoxides formed cis and trans conformations, but the optical rotation did not reveal any solid data because of the decomposition of 2. So, both of the conformations were subjected to quantum chemical calculation. By comparing the experimental and calculated ultraviolet spectra of 2a2d (Figure 4), the structures of 2b2 and 2d are consistent with those of experimental data. In order to confirm the structure of 2, the 13C NMR data of the four possible structures were also calculated by density functional theory (DFT). The data were evaluated based on the statistical parameters including correlation coefficient (R2) between experimental and calculated 13C NMR spectroscopic data with a linear regression, the maximum error (MaxErr), and mean absolute error (MAE). Comparison of all these parameters for calculated 13C chemical shifts of the four possible isomers with experimental data revealed the best fit was 2d (Table 2). Thus, the structure of 2 was determined and named 2,2-dioxidothiolutin.
Compound 3 was isolated as a yellow amorphous powder. The molecular formula of 3 was deduced to be C8H8N2O2S2 by the HRESIMS measurement (m/z [M + H]+ 229.0100, calcd for C8H9N2O2S2, 229.0100), accounting for six degrees of unsaturation (Figure S12). The 1H 13C and HSQC spectra (Figures S13–S15) displayed almost the same signals as those of reported thiolutin 3 [21]. In the HMBC spectrum (Figure S16), the correlations from H3-10 (δH 3.25) to C-3a (δC 136.0) and C-5 (δC 166.1), H-3 to C-3a and C-6a (δC 132.4), H-7-NH to C-6 (δC 114.8) and C-6a determined the chemical shifts of C-3, C-6, and C-6a. Thus, the chemical shifts for C-3a and C-6a should be swapped [21].

2.2. Biological Activity

These compounds were evaluated for their antimicrobial activities against C. albicans ATCC 10231, S. aureus ATCC 25923, Mycobacterium bovis (BCG Pasteur 1173P2), M. tuberculosis H37Rv (ATCC27294), and E. coli ATCC 25923. Compound 1 exhibited antibacterial activities against BCG, M. tuberculosis, and S. aureus with MIC values of 10, 10, and 100 μg/mL, respectively. Thiolutin (3) showed antibacterial activities against E. coli, BCG, M. tuberculosis, and S. aureus with MIC values of 6.25, 0.3125, 0.625, and 3.125 μg/mL, respectively (Table 3).

3. Materials and Methods

3.1. General Experimental Procedures

NMR spectra were obtained on a Bruker Avance 500 spectrometer with residual solvent peaks as references (DMSO-d6: δH 2.50, δC 39.52). High-resolution ESIMS measurements were obtained on an Accurate-Mass-Q-TOF LC/MS 6520 instrument (Santa Clara, CA, USA) in the positive ion mode. HPLC was performed using an Agilent 1200 Series separation module equipped with an Agilent 1200 Series diode array, Agilent 1200 Series fraction collector, and Agilent ZORBAX SB-C18 column (250 × 9.4 mm, 5 µm).

3.2. Microbial Material, Fermentation, Extraction, and Purification

Strain Streptomyces sp. BTBU20218885 was isolated from a mud sample collected from the intertidal zone, Xiamen, China, and grown on an ISP2 (yeast extract 0.4%, malt extract 1%, dextrose 0.4%, agar 2%; pH 7.2) agar plate at 28 °C. Colony characteristics of BTBU20218885 are shown in Figure S17. The genomic DNA of BTBU20218885 was extracted using a TINAamp Bacteria DNA Kit. PCR amplification of 16S rDNA was carried out by using universal primers (27f:5′-GAGAGTTTGATCCTGGCTCAG-3′; 1492r: 5′-CTACGGCTACCTTGTTACGA-3′). PCR amplification of the 16S rDNA was performed on TaKaRa PCR Thermal Cycler with the initial denaturation at 94 °C for 5 min, 30 cycles of denaturation (94 °C, 1 min), annealing (55 °C, 1 min), and elongation (72 °C, 1 min 15 s), and a final elongation at 72 °C for 10 min, in a 25 μL system (0.4 μL 20 μM of each primer, 2.5 μL 10× buffer, 2.5 μL 2.5 nM dNTP, 2 U rTap polymerase, and 1 μL DNA template). BTBU20218885 was identified as Streptomyces sp. by comparing the 16S rDNA sequence with the GenBank database using the BLAST program. A neighbor-joining (NJ) tree (Figure S18) was constructed using the software package Mega version 5 [26]. The strain was assigned the accession number BTBU20218885 in the culture collection at Beijing Technology and Business University, Beijing. The strain BTBU20218885 was inoculated on an ISP2 agar plate and cultured for 7 days. A 250 mL Erlenmeyer flask containing 40 mL of ISP2 medium was inoculated with BTBU20218885 and incubated at 28 °C (160 rpm) for 36 h. Aliquots (9 mL) of the seed cultures were aseptically transferred to 20 × 1 L Erlenmeyer flasks, each containing 300 mL of MPG media (glucose 1.0%, millet meal 2.0%, cotton seed gluten meal 2.0%, and MOPS 2.0%; pH 7.0), and the flasks were incubated at 28 °C, 160 rpm for 7 days. The culture broths were combined and centrifuged to yield a supernatant and a mycelial cake. The supernatant was extracted by equal volume of ethyl acetate (EtOAc, ×3 times), and the combined EtOAc extracts were evaporated to dryness in vacuo to give a dark residue. The residue was sequentially triturated with hexane, CH2Cl2, and MeOH to afford, after concentration in vacuo, hexane, CH2Cl2, and MeOH soluble fractions and precipitate. The precipitate was further purified by HPLC (Agilent ZORBAX SB-C18, 250 × 9.4 mm, 5 μm column, 3.0 mL/min, elution with 30% to 100% acetonitrile/H2O (0–20 min) to yield 1 (3.5 mg), 3 (2.6 mg), and 2 (13.2 mg).
Thiolopyrrolone A (1): Light-yellow amorphous powder; 1H and 13C NMR data, Table 1; HRESIMS m/z 621.0712 [M + H]+ (calcd for C24H25N6O6S4, 621.0713).
2,2-Dioxidothiolutin (2): Yellow amorphous powder; 1H and 13C NMR data, Table 1; HRESIMS m/z 260.9996 [M + H]+ (calcd for C8H9N2O4S2, 260.9998).

3.3. Biological Activity

Compounds 13 were evaluated for their antimicrobial activities in 96-well plates according to the Antimicrobial Susceptibility Testing Standards outlined by the Clinical and Laboratory Standards Institute Document M07-A7 (CLSI) and our previous report [27,28,29]. The MIC was defined as the minimum concentration of the compound that prevented visible growth of the microbes.

3.4. Computational Methods

A random conformational search of starting geometries in Discovery studio 4.0 was used to produce low-energy conformers within a 10 kcal/mol energy, which were subsequently optimized using the DFT method at mPW1PW91/6-31g(2d,p) level with GAUSSIAN 09 [30]. The optimized conformers were further checked by frequency calculation at the same level of theory, and resulted in no imaginary frequencies. The time-dependent density functional theory (TDDFT) calculations of their low-energy conformations within 0–2.5 kcal/mol were performed to simulate their UV–vis spectra at the same level. Similarly, their 13C NMR calculations were also carried out by GIAO method at the same level [31]. Solvent effect of dimethylsulfoxide was taken into account in the above calculations by using the polarizable continuum model (PCM).
Their theoretical UV–vis spectra based on Boltzmann statistics were generated in the program SpecDis 1.63 [32] by applying Gaussian band shape with a 0.40 eV exponential half-width from dipole-length rotational strengths. Statistical parameters were used to quantify the agreement between experimental and calculated data, including the correlation coefficient (R2) between experimental and calculated 13C NMR spectroscopic data with a linear regression, the mean absolute error (MAE), and the maximum error (MaxErr) [33]. The correlation coefficient (R2) was determined from a plot of δcalc (x axis) against δexp (y axis) for each particular compound. The mean absolute error (MAE) was defined as 1 n i = 1 n | δ calc ,   i δ exp ,   i | . The maximum error (MaxErr) was defined as max|δcalcδexp|.

4. Conclusions

In summary, chemical studies on the marine-derived Streptomyces sp. BTBU20218885 resulted in the characterization of three cyclized thiolopyrrolones, including a unique unsymmetrical thiolopyrrolone (1), 2,2-dioxidothiolutin (2), and the previously reported thiolutin (3). Dithiolopyrrolones are a class of structurally intriguing natural products with broad antibacterial spectrum [34]. Most of the analogues are characterized by a unique bicyclic pyrrolinonodithiole, with the differences in the substitution groups on N-4 and N-7 positions of the holothin core [35,36]; however, thiolopyrrolone A is the first sample of analogues with a macrocyclic skeleton. Compound 1 exhibited antibacterial activities against BCG, M. tuberculosis, and S. aureus with MIC values of 10, 10, and 100 μg/mL, respectively. Thiolutin (3) displayed potential antibacterial activities against E. coli, BCG, M. tuberculosis, and S. aureus with MIC values of 6.25, 0.3125, 0.625, and 3.125 μg/mL, respectively.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/md20030214/s1: Figures S1–S16: HRESIMS, 1D, and 2D NMR for compounds 13; Figure S17: Colony characteristics of BTBU20211089; Figure S18: Neighbor-joining phylogenetic tree of strain BTBU20211089.

Author Contributions

Data curation, F.S.; funding acquisition, F.S.; investigation, F.S., J.H., X.Z., W.X., J.Y. and S.L.; supervision, X.X.; writing—original draft, F.S. and X.X.; writing—review and editing, F.S., J.H., X.Z. and X.X. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by grants from the National Natural Science Foundation of China (81973204), the Key Lab of Marine Bioactive Substance and Modern Analytical Technique, SOA (MBSMAT-2019-06), and Research Foundation for Advanced Talents of Beijing Technology and Business University (19008021176).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the text.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Dhasarathan, P.; AlSalhi, M.S.; Devanesan, S.; Subbiah, J.; Ranjitsingh, A.J.A.; Binsalah, M.; Alfuraydi, A.A. Drug resistance in Candida albicans isolates and related changes in the structural domain of Mdr1 protein. J. Infect. Public Health 2021, 14, 1848–1853. [Google Scholar] [CrossRef]
  2. Miklasińska-Majdanik, M. Mechanisms of Resistance to Macrolide Antibiotics among Staphylococcus aureus. Antibiotics 2021, 10, 1406. [Google Scholar] [CrossRef] [PubMed]
  3. Poirel, L.; Madec, J.-Y.; Lupo, A.; Schink, A.-K.; Kieffer, N.; Nordmann, P.; Schwarz, S.; Aarestrup, F.M.; Schwarz, S.; Shen, J.; et al. Antimicrobial resistance in Escherichia coli. Microbiol. Spectr. 2018, 6, ARBA-0026-2017. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Chizimu, J.Y.; Solo, E.S.; Bwalya, P.; Tanomsridachchai, W.; Chambaro, H.; Shawa, M.; Kapalamula, T.F.; Lungu, P.; Fukushima, Y.; Mukonka, V.; et al. Whole-Genome Sequencing Reveals Recent Transmission of Multidrug-Resistant Mycobacterium tuberculosis CAS1-Kili Strains in Lusaka, Zambia. Antibiotics 2022, 11, 29. [Google Scholar] [CrossRef] [PubMed]
  5. Barka, E.A.; Vatsa, P.; Sanchez, L.; Gaveau-Vaillant, N.; Jacquard, C.; Klenk, H.P.; Clément, C.; Ouhdouch, Y.; van Wezel, G.P. Taxonomy, physiology, and natural products of actinobacteria. Microbiol. Mol. Biol. Rev. 2016, 80, 1–43. [Google Scholar] [CrossRef] [Green Version]
  6. Berdy, J. Thoughts and facts about antibiotics: Where we are now and where we are heading. J. Antibiot. 2012, 65, 385–395. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Mast, Y.; Stegmann, E. Actinomycetes: The antibiotics producers. Antibiotics 2019, 8, 105. [Google Scholar] [CrossRef] [Green Version]
  8. Takahashi, Y.; Nakashima, T. Actinomycetes, an inexhaustible source of naturally occurring antibiotics. Antibiotics 2018, 7, 45. [Google Scholar] [CrossRef] [Green Version]
  9. Subramani, R.; Aalbersberg, W. Marine actinomycetes: An ongoing source of novel bioactive metabolites. Microbiol. Res. 2012, 167, 571–580. [Google Scholar] [CrossRef]
  10. Shaaban, M.; Shaaban, K.A.; Kelter, G.; Fiebig, H.H.; Laatsch, H. Mansouramycins E–G, cytotoxic isoquinolinequinones from marine Streptomycetes. Mar. Drugs 2021, 19, 715. [Google Scholar] [CrossRef]
  11. Shen, X.; Wang, X.; Huang, T.; Deng, Z.; Lin, S. Naphthoquinone-based meroterpenoids from marine-derived Streptomyces sp. B9173. Biomolecules 2020, 10, 1187. [Google Scholar] [CrossRef] [PubMed]
  12. Wu, J.; Zhu, Y.; Zhang, M.; Li, H.; Sun, P. Micaryolanes A and B, two new caryolane-type sesquiterpenoids from marine Streptomyces sp. AH25. Chem. Biodivers. 2020, 17, e2000769. [Google Scholar] [CrossRef] [PubMed]
  13. Chang, Y.; Xing, L.; Sun, C.; Liang, S.; Liu, T.; Zhang, X.; Zhu, T.; Pfeifer, B.A.; Che, Q.; Zhang, G.; et al. Monacycliones G–K and ent-gephyromycin A, angucycline derivatives from the marine-derived Streptomyces sp. HDN15129. J. Nat. Prod. 2020, 83, 2749–2755. [Google Scholar] [CrossRef] [PubMed]
  14. Liu, M.; Yang, Y.-J.; Gong, G.; Li, Z.; Zhang, L.; Guo, L.; Xu, B.; Zhang, S.M.; Xie, Z.P. Angucycline and angucyclinone derivatives from the marine-derived Streptomyces sp. Chirality 2022, 34, 421–427. [Google Scholar] [CrossRef]
  15. Guo, L.; Yang, Q.; Wang, G.; Zhang, S.; Liu, M.; Pan, X.; Pescitelli, G.; Xie, Z. Ring D-modified and highly reduced angucyclinones from marine dediment-derived Streptomyces sp. Front. Chem. 2021, 9, 756962. [Google Scholar] [CrossRef]
  16. Cho, E.; Kwon, O.-S.; Chung, B.; Lee, J.; Sun, J.; Shin, J.; Oh, K.B. Antibacterial activity of chromomycins from a marine-derived Streptomyces microflavus. Mar. Drugs 2020, 18, 522. [Google Scholar] [CrossRef]
  17. Karim, M.R.U.; In, Y.; Zhou, T.; Harunari, E.; Oku, N.; Igarashi, Y. Nyuzenamides A and B: Bicyclic peptides with antifungal and cytotoxic activity from a marine-derived Streptomyces sp. Org. Lett. 2021, 23, 2109–2113. [Google Scholar] [CrossRef]
  18. Guo, Z.; Ma, S.; Khan, S.; Zhu, H.; Zhang, B.; Zhang, S.; Jiao, R. Zhaoshumycins A and B, two unprecedented antimycin-type depsipeptides produced by the marine-derived Streptomyces sp. ITBB-ZKa6. Mar. Drugs 2021, 19, 624. [Google Scholar] [CrossRef]
  19. Çetinel Aksoy, S.; Küçüksolak, M.; Uze, A.; Bedir, E. Benzodiazepine derivatives from marine-derived Streptomyces cacaoi 14CM034. Rec. Nat. Prod. 2021, 15, 602–607. [Google Scholar] [CrossRef]
  20. Peng, J.; Zhang, Q.; Jiang, X.; Ma, L.; Long, T.; Cheng, Z.; Zhang, C.; Zhu, Y. New piericidin derivatives from the marine-derived Streptomyces sp. SCSIO 40063 with cytotoxic activity. Nat. Prod. Res. 2021. [Google Scholar] [CrossRef]
  21. Xu, X.; Han, J.; Lin, R.; Polyak, S.W.; Song, F. Two new piperazine-triones from a marine-derived Streptomycetes sp. strain SMS636. Mar. Drugs 2019, 17, 186. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Zhang, X.; He, H.; Ma, R.; Ji, Z.; Wei, Q.; Dai, H.; Zhang, L.; Song, F. Madurastatin B3, a rare aziridine derivative from actinomycete Nocardiopsis sp. LS150010 with potent anti-tuberculosis activity. J. Ind. Microbiol. Biotechnol. 2017, 44, 589–594. [Google Scholar] [CrossRef] [PubMed]
  23. Chen, C.; Chen, X.; Ren, B.; Guo, H.; Abdel-Mageed, W.M.; Liu, X.; Song, F.; Zhang, L. Characterization of Streptomyces sp. LS462 with high productivity of echinomycin, a potent antituberculosis and synergistic antifungal antibiotic. J. Ind. Microbiol. Biotechnol. 2021, 48, kuab079. [Google Scholar] [CrossRef] [PubMed]
  24. Song, F.; Yang, N.; Khalil, Z.G.; Salim, A.A.; Han, J.; Bernhardt, P.V.; Lin, R.; Xu, X.; Capon, R.J. Bhimamycin J, a rare benzo[f]isoindole-dione alkaloid from the marine-derived actinomycete Streptomyces sp. MS180069. Chem. Biodivers. 2021, 18, e2100674. [Google Scholar] [CrossRef] [PubMed]
  25. Lamari, L.; Zitouni, A.; Dob, T.; Sabaou, N.; Lebrihi, A.; Germain, P.; Seguin, E.; Tillequin, F. New dithiolopyrrolone antibiotics from Saccharothrix sp. SA 233. II. Physicochemical properties and structure elucidation. J. Antibiot. 2002, 55, 702–706. [Google Scholar] [CrossRef] [Green Version]
  26. Thompson, J.D.; Higgins, D.G.; Gibson, T.J. Clustal-W-Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22, 4673–4680. [Google Scholar] [CrossRef] [Green Version]
  27. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 7th ed.; Approved standard; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2008. [Google Scholar]
  28. Han, J.; Yang, N.; Wei, S.; Jia, J.; Lin, R.; Li, J.; Bi, H.; Song, F.; Xu, X. Dimeric hexylitaconic acids from the marine-derived fungus Aspergillus welwitschiae CUGBMF180262. Nat. Prod. Res. 2022, 36, 578–585. [Google Scholar] [CrossRef]
  29. Wang, Q.; Song, F.; Xiao, X.; Huang, P.; Li, L.; Monte, A.; Abdel-Mageed, W.M.; Wang, J.; Guo, H.; He, W.; et al. Abyssomicins from the South China Sea deep-sea sediment Verrucosispora sp.: Natural thioether Michael addition adducts as antitubercular prodrugs. Angew. Chem. Int. Ed. Engl. 2013, 52, 1231–1234. [Google Scholar] [CrossRef] [Green Version]
  30. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G.A.; et al. Gaussian 09, Revision E.01; Gaussian, Inc.: Wallingford, CT, USA, 2009. [Google Scholar]
  31. Wolinski, K.; Hilton, J.F.; Pulay, P. Efficient Implementation of the Gauge-Independent Atomic Orbital Method for NMR chemical shift calculations. J. Am. Chem. Soc. 1990, 112, 8251–8260. [Google Scholar] [CrossRef]
  32. Bruhn, T.; Schaumlöffel, A.; Hemberger, Y.; Bringmann, G. SpecDis: Quantifying the comparison of calculated and experimental electronic circular dichroism spectra. Chirality 2013, 25, 243–249. [Google Scholar] [CrossRef]
  33. Tran, T.D.; Pham, N.B.; Quinn, R.J. Structure determination of pentacyclic pyridoacridine alkaloids from the Australian marine organisms Ancorina geodides and Cnemidocarpa stolonifera. Eur. J. Org. Chem. 2014, 2014, 4805–4816. [Google Scholar] [CrossRef]
  34. Li, B.; Wever, W.J.; Walsh, C.T.; Bowers, A.A. Dithiolopyrrolones: Biosynthesis, synthesis, and activity of a unique class of disulfide-containing antibiotics. Nat. Prod. Rep. 2014, 31, 905–923. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Qin, Z.; Huang, S.; Yu, Y.; Deng, H. Dithiolopyrrolone Natural Products: Isolation, Synthesis and Biosynthesis. Mar. Drugs 2013, 11, 3970–3997. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Huang, S.; Tong, M.H.; Qin, Z.; Deng, Z.; Deng, H.; Yu, Y. Identification and characterization of the biosynthetic gene cluster of thiolutin, a tumor angiogenesis inhibitor, in Saccharothrix algeriensis NRRL B–24137. Anticancer Agents Med. Chem. 2015, 15, 277–284. [Google Scholar] [CrossRef]
Figure 1. Chemical structures of 13.
Figure 1. Chemical structures of 13.
Marinedrugs 20 00214 g001
Figure 2. Key HMBC (arrows) correlations in 1 and 2.
Figure 2. Key HMBC (arrows) correlations in 1 and 2.
Marinedrugs 20 00214 g002
Figure 3. Four possible structures of 2 for calculating 13C NMR data in DMSO-d6.
Figure 3. Four possible structures of 2 for calculating 13C NMR data in DMSO-d6.
Marinedrugs 20 00214 g003
Figure 4. Calculated UV spectra for 2a2d and UV spectrum for compound 2.
Figure 4. Calculated UV spectra for 2a2d and UV spectrum for compound 2.
Marinedrugs 20 00214 g004
Table 1. 1H (500 MHz) and 13C NMR (125 MHz) data of 13 (DMSO-d6).
Table 1. 1H (500 MHz) and 13C NMR (125 MHz) data of 13 (DMSO-d6).
Position123
δCδH (J in Hz)δCδH (J in Hz)δCδH (J in Hz)
3/3′/3″111.9/112.5/112.86.58/6.36/6.54, s109.67.56, s111.07.34, s
3a/3a′/3a″137.1/131.9/133.8 145.5 136.0
5/5′/5″164.0/163.7/163.8 164.3 166.1
6/6′/6″130.7/129.8/132.7 114.1 114.8
6a/6a′/6a″124.6/124.6/126.4 123.1 132.4
8/8′/8″168.4/168.3/167.9 170.5 168.8
9/9′/9″22.9/22.8/22.82.07/2.06/2.07, s22.62.10, s22.42.02, s
10/10′/10″29.9/29.2/29.23.19/3.47/3.40, s27.93.10, s27.53.25, s
7/7′/7″-NH 10.27/10.21/10.17, s - 9.99, s
Table 2. Comparison of calculated (TMS as a reference standard) and experimental 13C data for 2.
Table 2. Comparison of calculated (TMS as a reference standard) and experimental 13C data for 2.
Position2a2b12b22c2d2
3115.2110.2111.8107.4103.9109.6
3a129.4147.5140.2121.2140.2145.5
5162.1160.5159.0159.6159.2164.3
6112.9130.4127.9131.1121.1114.1
6a138.1135.9131.3124.5129.5123.1
8167.3164.1163.5163.4163.9170.5
921.323.122.823.022.622.6
1027.627.426.826.427.327.9
R20.97230.97760.98120.95340.9898
MAE5.65.45.47.34.6
MaxErr16.116.313.824.37.0
Table 3. Antibacterial activities of compounds 13 (MIC, μg/mL).
Table 3. Antibacterial activities of compounds 13 (MIC, μg/mL).
NumberC. albicansS. aureusBCGM. tuberculosisE. coli
1>2001001010>100
2>20050-->200
3>2003.1250.31250.6256.25
Control1 a1 b0.05 c0.025 c1 d
a Rapamycin, b vancomycin, c isoniazid, d ciprofloxacin.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Song, F.; Hu, J.; Zhang, X.; Xu, W.; Yang, J.; Li, S.; Xu, X. Unique Cyclized Thiolopyrrolones from the Marine-Derived Streptomyces sp. BTBU20218885. Mar. Drugs 2022, 20, 214. https://doi.org/10.3390/md20030214

AMA Style

Song F, Hu J, Zhang X, Xu W, Yang J, Li S, Xu X. Unique Cyclized Thiolopyrrolones from the Marine-Derived Streptomyces sp. BTBU20218885. Marine Drugs. 2022; 20(3):214. https://doi.org/10.3390/md20030214

Chicago/Turabian Style

Song, Fuhang, Jiansen Hu, Xinwan Zhang, Wei Xu, Jinpeng Yang, Shaoyong Li, and Xiuli Xu. 2022. "Unique Cyclized Thiolopyrrolones from the Marine-Derived Streptomyces sp. BTBU20218885" Marine Drugs 20, no. 3: 214. https://doi.org/10.3390/md20030214

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop